• Explore /
  • Poster
  • / <span>Real-world analysis of commercially insured and Medicare Advantage patients with advanced cancer and rates of molecular testing.</span>

Real-world analysis of commercially insured and Medicare Advantage patients with advanced cancer and rates of molecular testing.

Abstract Poster

Authors

null

Stacey DaCosta Byfield

Optum Labs, Eden Prairie, MN

Stacey DaCosta Byfield , Bela Bapat , Laura Becker , Brock Schroeder , Scott Spencer , Ismini Chatzitheofilou , Damon Hostin , John Leonard Fox

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Real-World Data/Outcomes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6633)

DOI

10.1200/JCO.2023.41.16_suppl.6633

Abstract #

6633

Poster Bd #

125

Abstract Disclosures

Similar Posters

First Author: Mo Yang

First Author: Anik Patel

Poster

2024 ASCO Annual Meeting

Characterization of diverse targetable <em>ERBB2</em> alterations in 512,993 patients with solid tumors.

Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.

First Author: Dazhi Liu

First Author: Christine Megerdichian Parseghian